Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients

Ai-Ping Yang1, Hui-Ming Li2, Wen-Qiang Tao3

  • 1Department of Clinical Laboratory, Zhejiang Xiaoshan Hospital, Hangzhou, Zhejiang Province, China.

Aging
|June 3, 2020
PubMed

Insights

Key laboratory markers like neutrophil-to-lymphocyte ratio (NLR) and D-dimer (D-D) can help identify severe COVID-19 cases early. Lymphopenia and cytokine storm severity correlate with disease progression.

Area of Science:

  • Immunology
  • Clinical Medicine
  • Virology

Background:

  • Coronavirus disease 2019 (COVID-19) presents with diverse clinical manifestations.
  • Understanding laboratory markers is crucial for assessing disease severity and prognosis.

Purpose of the Study:

  • To evaluate the clinical significance of abnormal laboratory results in COVID-19 patients.
  • To aid clinicians in accurate diagnosis and treatment strategies for COVID-19.

Main Methods:

  • Analysis of peripheral blood samples from 93 COVID-19 patients.
  • Flow cytometry for lymphocyte subsets and immunoassays for cytokine profiles.
  • Statistical analysis including ROC curves and COX regression models for prognostic value.

Main Results:

  • Elevated neutrophil-to-lymphocyte ratio (NLR), D-dimer (D-D), and specific cytokines (IL-6, IL-10, IL-2, IFN-γ) correlated with COVID-19 severity.
  • Lymphopenia and a proinflammatory cytokine storm were more pronounced in severe cases.
  • D-dimer levels significantly increased with disease severity, posing a risk for disseminated intravascular coagulation.
  • Renal function damage often preceded cardiac and liver dysfunction in severe COVID-19.

Conclusions:

  • Lymphopenia and cytokine storm severity are associated with COVID-19 disease severity.
  • Advanced age, NLR, D-D, and cytokine levels are potential prognostic factors for early identification of severe COVID-19.
  • Laboratory markers provide valuable insights into COVID-19 progression and patient outcomes.
Abstract

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
264
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
973
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
690
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
176
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.0K